Biocatalyst Market to cross USD 950 million by 2032, says Global Market Insights Inc.
29 mars 2023 06h10 HE
|
Global Market Insights Inc.
Selbyville, Delaware, March 29, 2023 (GLOBE NEWSWIRE) -- Biocatalyst market value is expected to be worth USD 950 million by 2032, According to the latest report by Global Market Insights Inc. As...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN ATLANTA, GEORGIA
27 mars 2023 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, March 27, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
By 2033, The Hydrolyzed Animal Protein Market is anticipated to reach US$ 838.43 million, recording a CAGR of 6.1% | Future Market Insights, Inc.
24 mars 2023 09h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 24, 2023 (GLOBE NEWSWIRE) -- The hydrolyzed animal protein market is expected to reach US$ 838.43 million by 2033, recording a CAGR of 6.1% over the forecast period, from an...
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Big Sky, Montana
17 mars 2023 10h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, March 17, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the...
PetVivo Holdings, Inc. to Exhibit and Dr. Erik Kleeman of Ethos Veterinary Health to Present Canine Study Results at the Veterinary Orthopedic Society Annual Conference
10 mars 2023 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, March 10, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA
13 févr. 2023 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Feb. 13, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PetVivo Reports Third Quarter of Fiscal 2023 Financial Results
09 févr. 2023 16h00 HE
|
PetVivo Holdings, Inc.
Conference call begins at 4:00 p.m. Central time today EDINA, MN , Feb. 09, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW), an emerging biomedical device company...
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2022
02 févr. 2023 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 02, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE MINNESOTA VETERINARY MEDICAL ASSOCIATION ANNUAL MEETING IN MINNEAPOLIS, MINNESOTA
30 janv. 2023 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 30, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PETVIVO HOLDINGS, INC. TO PARTICIPATE IN THE LYTHAM PARTNERS INVESTOR SELECT CONFERENCE
26 janv. 2023 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...